Literature DB >> 26756261

An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.

Chantal B Bartels1, Kamaria C Cayton, Farah S Chuong, Kristine Holthouser, Sara E Arian, Tara Abraham, James H Segars.   

Abstract

Fibroids are the most common tumor of the female reproductive tract, but approved medical treatments are limited. Patients demand uterine-sparing treatments which preserve fertility and avoid surgery. We systematically reviewed PubMed and Cochrane databases from January 1985 to November 2015 for evidence-based medical therapies for fibroids in the context of disease prevention, treatment of early disease, treatment of symptomatic disease, and preoperative management. We identified 2182 studies, of which 52 studies met inclusion and exclusion criteria. Published data affirm the efficacy of multiple agents, which are promising avenues for the development of medical alternatives to surgery.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26756261     DOI: 10.1097/GRF.0000000000000171

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  17 in total

1.  Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.

Authors:  Erica E Marsh; Ayman Al-Hendy; Dale Kappus; Alex Galitsky; Elizabeth A Stewart; Majid Kerolous
Journal:  J Womens Health (Larchmt)       Date:  2018-09-19       Impact factor: 2.681

Review 2.  Uterine leiomyomas revisited with review of literature.

Authors:  Rishi Philip Mathew; Swati Francis; Vinayak Jayaram; Shameema Anvarsadath
Journal:  Abdom Radiol (NY)       Date:  2021-05-31

3.  Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial.

Authors:  Jeris Cox; Minnie Malik; Joy Britten; Terrence Lewis; William H Catherino
Journal:  Reprod Sci       Date:  2017-09-20       Impact factor: 3.060

Review 4.  A Systematic Review of Vitamin D and Fibroids: Pathophysiology, Prevention, and Treatment.

Authors:  Abigail Combs; Bhuchitra Singh; Elisabeth Nylander; Md Soriful Islam; Ha Vi Nguyen; Elissa Parra; Ameerah Bello; James Segars
Journal:  Reprod Sci       Date:  2022-08-12       Impact factor: 2.924

5.  Effects of total laparoscopic hysterectomy on the clinical outcomes of patients with uterine fibroids.

Authors:  Lang Zheng; Dan Liu; Chunyan Hu
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

6.  Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study.

Authors:  Mostafa A Borahay; Xiao Fang; Jacques G Baillargeon; Gokhan S Kilic; Darren F Boehning; Yong-Fang Kuo
Journal:  Am J Obstet Gynecol       Date:  2016-06-28       Impact factor: 8.661

7.  The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid Receptor.

Authors:  Benjamin Small; Charles E F Millard; Edwina P Kisanga; Andreanna Burman; Anika Anam; Clare Flannery; Ayman Al-Hendy; Shannon Whirledge
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

8.  Endometrial Sampling for Preoperative Diagnosis of Uterine Leiomyosarcoma.

Authors:  Rosanne M Kho; Vrunda B Desai; Peter E Schwartz; Jason D Wright; Cary P Gross; Lindsey M Hutchison; Francis P Boscoe; Haiqun Lin; Xiao Xu
Journal:  J Minim Invasive Gynecol       Date:  2021-07-13       Impact factor: 4.137

Review 9.  Alternative Oral Agents in Prophylaxis and Therapy of Uterine Fibroids-An Up-to-Date Review.

Authors:  Michał Ciebiera; Krzysztof Łukaszuk; Błażej Męczekalski; Magdalena Ciebiera; Cezary Wojtyła; Aneta Słabuszewska-Jóźwiak; Grzegorz Jakiel
Journal:  Int J Mol Sci       Date:  2017-12-01       Impact factor: 5.923

Review 10.  The role of levonorgestrel intrauterine systems in the treatment of symptomatic fibroids.

Authors:  Wojciech Wrona; Anna Stępniak; Piotr Czuczwar
Journal:  Prz Menopauzalny       Date:  2017-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.